What about the influence of COVID-19 on the biotech financing landscape?

Panelist: Geraldine O’keeffe (Partner at LSP), Arthur Franken (Partner at Gilde), Krijn de Nood (CEO of Meatable) and Jan de Kerpel (Managing director of Kempen).

Guided by ProQR CEO Daniel de Boer, the panel will reflect on how to raise capital during and after the pandemic, and how today’s crisis will affect both biotech businesses, capital markets and investors.

Webinar platform: ZOOM

Registration: registration is required (free of charge). Register here